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Abstract
Aim—Protection achieved by ischemic preconditioning is dependent on A2B adenosine receptors
(A2BAR) in rabbit and mouse hearts and, predictably, an A2BAR agonist protects them. But it is
controversial whether cardiomyocytes themselves actually express A2BAR. The present study
tested whether A2BAR could be demonstrated on rat cardiomyocytes.
Methods and Results—Isolated rat hearts experienced 30 min of ischemia and 120 min of
reperfusion. The highly selective, cell-permeant A2BAR agonist BAY60-6583 (500 nM) infused at
reperfusion reduced infarct size from 40.4±2.0 % of the risk zone in control hearts to 19.9±2.8 %
indicating that A2BAR are protective in rat heart as well. Furthermore, BAY60-6583 reduced
calcium-induced mitochondrial permeability transition in isolated rat cardiomyocytes. A2BAR
protein could be demonstrated in isolated cardiomyocytes by western blotting. In addition,
message for A2BAR was found in individual cardiomyocytes using quantitative RT-PCR.
Surprisingly, immunofluorescence microscopy did not show A2BAR on the cardiomyocyte's
sarcolemma but rather at intracellular sites. Co-staining with MitoTracker Red in isolated
cardiomyocytes revealed A2BAR are localized to mitochondria. Western blot analysis of a
mitochondrial fraction from either rat heart biopsies or isolated cardiomyocytes revealed a strong
A2BAR band.
Conclusions—Thus the present study demonstrates that activation of A2BAR is strongly
cardioprotective in rat heart and suppresses transition pores in isolated cardiomyocytes, and
A2BAR are expressed in individual cardiomyocytes. However, surprisingly, A2BAR are present in
or near mitochondria rather than on the sarcolemma as are other adenosine receptors. Because
A2BAR signalling is thought to result in inhibition of mitochondrial transition pores, this
convenient location may be important.
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Introduction
Ischemic preconditioning (IPC) triggers powerful endogenous signalling that ultimately
makes the heart resistant to infarction from ischemia. A key step in preconditioning's signal
transduction pathway is activation of adenosine A2B receptors (A2BAR) early in reperfusion
[8,10,25,43]. Ischemic postconditioning, another endogenous cardioprotective phenomenon,
also depends on activation of A2BAR [33]. Analogously the highly selective A2B agonist
BAY60-6583 given at reperfusion reduces infarct size in rabbit hearts following prolonged
myocardial ischemia [21].
A2BAR are G protein-coupled receptors (GPCR) that communicate through both Gαs and
Gαq, which in turn lead to increased cytosolic cAMP, inositol trisphosphate and Ca2+ [23].
There is agreement that coronary endothelial cells contain A2BAR [14,39], but there is
discrepant information about the expression of A2B on cardiomyocytes, the cells that IPC
must ultimately protect. To address this question, Yang et al. [47] replaced exon 1 of the
A2BAR gene in transgenic mice with a reporter construct containing β-Gal. They did not
detect β-Gal expression in heart muscle indicating that expression of the receptors was either
absent or too low to detect. On the other hand, Morrison and colleagues saw a positive
inotropic response to the potent, albeit nonselective, A2BAR agonist 5’- (N-
ethylcarboxamido) adenosine (NECA) in A2aAR knockout mice suggesting that some
A2BAR must reside on or within cardiomyocytes [30]. Furthermore, Liang and Haltiwanger
[22] studied contractility and cAMP production of cultured chick embryonic ventricular
cells and again found responses to A2BAR agonists. Finally, a recent report by Xin at al.
[45] contributed to the controversy; they could find no functional evidence for sarcolemmal
A2BAR in isolated rabbit cardiomyocytes.
In the present study we address the question whether A2BAR are expressed in rat ventricular
cardiomyocytes. First we tested whether a selective A2BAR agonist is as protective in intact
rat hearts and isolated cardiomyocytes as it is in rabbits. Then, using antibodies to A2BAR
we performed immunofluorescence, FACS analysis, and western blotting to try to localize
the receptors.
Methods
The present study was conducted in accordance with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health (NIH Publication No.
85-23, revised 1996). The experimental protocols were approved by the local authorities of
Mecklenburg-Vorpommern (Germany) and the University of North Carolina (USA).
Isolated rat hearts and infarct size measurement
Adult Wistar rats of either sex were used. Heart isolation and determination of infarct size
were performed as described previously in detail [26]. Control hearts (n=6) were exposed to
30 min of regional ischemia by occluding a snared coronary artery and then 120 min of
reperfusion. The second group (n=10) was treated with 500 nM BAY60-6583 for 65 min
starting 5 min before reperfusion. The third group (n=6) received 500 nM BAY60-6583 in
the presence of the highly selective A2BAR antagonist MRS1754 (20 nM). At the end of the
experiment risk zone was determined with green fluorescent microspheres injected into the
aorta perfusate after religation of the snared coronary artery and infarct size was determined
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with triphenyltetrazolium chloride staining of the sliced left ventricle. Infarct size is
presented as a percentage of the risk zone. BAY60-6583 and MRS1754 were dissolved in
dimethyl sulfoxide (DMSO) before being further diluted in perfusion buffer, resulting in
DMSO concentrations lower than 0.01 %. The ability of BAY60-6583 to enter
cardiomyocytes has been demonstrated (supplemental Fig. S1).
Isolated rat cardiomyocytes and assessment of mitochondrial membrane potential ΔΨm
Hearts were excised and retrogradely perfused with Krebs-Henseleit-buffer containing 25
μM calcium and collagenase type II at 37°C as previously described [12]. Viable ventricular
myocytes were separated by centrifugation in a 4% bovine serum albumin gradient, seeded
on laminin coated four-well plates and cultured in medium M199 containing 0.2% BSA, 5
mM creatine, 2 mM L-carnithine, 5 mM taurine and penicillin and streptomycin (each 100
U/ml). Four hours after isolation cells were washed once and loaded for 20 min with 100 nM
tetramethylrhodamine ethyl ester (TMRE) (Molecular Probes Inc., Eugene, OR, USA)
which causes cells to fluoresce in proportion to their mitochondrial membrane potential
(ΔΨm). A reduction in TMRE fluorescence served as an indicator of the loss of ΔΨm,
which would occur with mitochondrial permeability transition pore (mPTP) formation. If
required, BAY 60-6583 (100 nM) and MRS1754 (100 nM) were added 5 min before TMRE
loading to mimic a preconditioning protocol. Afterwards cells were washed with TMRE-free
medium and then incubated with the selective calcium ionophore calcimycin (1 μM), which
is known to induce mPTP formation similar to that seen at reperfusion following myocardial
ischemia [32]. Fluorescence intensity was measured at 582 nm (FL-2 channel) using a
Becton Dickinson (Heidelberg, Germany) FACSCalibur and CellQuest software after 35
min of calcimycin exposure and expressed as the mean fluorescence for each measurement.
Four groups of TMRE-loaded myocytes were studied: treatment with calcimycin alone or
with the additional agents BAY 60-6583, MRS1754, or BAY 60-6583 plus MRS1754 (each
n=9).
Isolated mitochondria from intact rat hearts and isolated cardiomyocytes
Cardiac mitochondria were isolated using standard centrifugation techniques. Briefly, hearts
were minced in ice-cold solution A (250 mM sucrose, 10 mM Tris-HCl, 0.1 mM EGTA and
0.5% BSA, pH 7.4). Tissue pieces were then homogenized using a Potter S (Braun Biotech
International, Melsungen, Germany) at 1000 rpm and subjected to stepwise centrifugation.
The homogenate was centrifuged at 500 g and the supernatant at 9,000 g. The resulting
pellet (crude mitochondrial fraction) was resuspended in ice-cold solution B (250 mM
sucrose, 10 mM Tris-HCl, 0.1 mM EGTA, pH 7.4). To further purify mitochondria the
resulting suspension was alternately spun at 9,000g and washed 5 times.
Mitochondria were harvested from isolated cardiomyocytes at the end of the cell isolation
procedure by directly suspending the cells in solution A. The rest of the preparation was
identical to that described above.
Isolation and purification of cardiac sarcolemma
To obtain purified sarcolemma two different protocols were used. First, hearts were
homogenized as described above and the homogenate centrifuged at 9,000 g to remove
intracellular organelles including mitochondria. The supernatant was centrifuged at 100,000
g and the pellet was resuspended in Tris-HCl (5 mM, pH 7.4) and further used for Western
blot analysis. The second protocol included an additional pellet purification step with a
sucrose gradient (38 % sucrose in 5 mM HEPES, pH 7.4). The pellet was centrifuged at
280,000 g and the interphase containing purified sarcolemma was washed in Tris-sucrose
(10 mM and 250 mM, pH 7.4) prior to Western blot analysis.
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A2BAR expression by quantitative RT-PCR
Isolated rat cardiomyocytes were plated in a glass chamber and observed at 30 X using an
Olympus BX-51 microscope. Under micromanipulator control cardiomyocytes (5-10 cells)
were harvested by drawing them into micropipettes pulled from 1.5 mm diameter
borosilicate glass (Drummond Scientific Company, Broomall, PA). Care was taken to
exclude all other cell types. After collection, cells were immediately transferred to a 500 μL
microcentrifuge tube containing protease K and RNAase inhibitors by breaking the pipette
tip against the bottom of the tube and expelling the contents of the pipette. Total mRNA was
isolated using Trizol (Invitrogen) reagent. RNA was converted to cDNA using reverse
transcriptase. GAPDH and A2BAR mRNA sequences were identified using Rat Genome
Resources of NCBI (http://www.ncbi.nlm.nih.gov). Primer pairs for GAPDH (forward:
CAGGTTGTCTCCTGCGACTT, reverse: ATGTAGGCCATGAGGTCCAC) and A2BAR
(forward: CCAAGGACAAGCCCAAATG, reverse: CCGTCTGGCAGAGAACGTAT)
were designed using Primer3 program. Gene expressions were assessed by quantitative RT-
PCR using QuantiTect SYBR Green PCR Kit (Qiagen) and ABI 7900HT Fast Real-Time
PCR System. Relative quantities of message were calculated from cycle threshold (Ct)
measurements. Ct values were standardized to GAPDH for each sample and then subjected
to standard calculations. Dissociation curves were also initially evaluated for each qPCR
sample to qualitatively confirm assay integrity. The amplified product was analyzed on an
agarose gel to confirm its expected molecular size. Additionally, two target bands were
selected from two samples and purified with Wizard SV gel and PCR clean-up system
(Promega, WI). The PCR products (10 ng) and the primers (10 pmol) were used for RNA
sequencing at the University of North Carolina Genome Analysis Facility. The raw data
were processed and analyzed with Sequencher (Version 4.8.) and ChromasPro.
Immunofluorescence
Either cryosections of the heart, isolated cardiomyocytes, or mitochondria were studied.
Cryosections were prepared after rinsing the heart of blood with ice cold saline (0.9%)
delivered retrogradely through the aorta. After cutting the heart from base to apex into
parallel slices which were snap-frozen in liquid nitrogen, 5 μm-thick cryosections were cut
from the snap-frozen slices (Leica CM 1900, Leica Microsystems, Nussloch, Germany).
Heart sections were fixed on SuperFrost Plus microscope slides (R. Langenbrinck,
Teningen, Germany) in acetone and permeabilized in 0.5% Triton X-100 in PBS. After a
blocking step in 5% FCS in PBS for one hour, staining was carried out overnight at 4°C
using either the primary A2BAR antibody or affinity-purified IgG in a corresponding
concentration. A secondary antibody conjugated to Alexa Fluor 488 was used. Staining of
the nuclei was performed by using propidium iodide (1 μg/ml, Sigma, St. Louis, MO). Adult
ventricular cardiomyocytes were isolated as described above. Cells were plated on laminin-
coated coverslips and incubated in modified CCT-medium 199 as previously described [34].
After 4 h of incubation cardiomyocytes were stained with a mitochondria-specific dye (50
nM MitoTracker Red CMXRos, Invitrogen, Karlsruhe, Germany) and fixed in 2%
paraformaldehyde. Finally, the protocol described above for cryosections was used.
MitoTracker-loaded cells were first exposed to the A2BAR primary antibody. Native cells
were incubated with either a combination of primary antibodies against A2BAR and α-
actinin or against A2BAR and Na+/K+-ATPase and then exposed to secondary antibodies
conjugated to Alexa Fluor 488 and Alexa Fluor 568 (Invitrogen, Karlsruhe, Germany).
Staining of the nuclei was performed by 4'-6-diamidino-2-phenylindole (DAPI) incubation
(0.2 μg/ml, Roth, Karlsruhe, Germany). Fluorescent micrographs were taken with a confocal
laser scanning microscope (Leica SP5, Wetzlar, Germany). Representative pictures from at
least four independent heart or cell preparations are shown. Additionally human embryonic
kidney (HEK) 293 cells overexpressing human A2BAR were treated with the A2B antibody
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and then a fluorochrome-linked secondary antibody. These experiments are more fully
described in the online supplement.
Mitochondria were isolated as described above, blocked in Solution A containing BSA, and
incubated with primary antibodies (0.1 μg/200 μg mitochondria) against A2BAR, Gαs, and
markers of mitochondria [voltage-dependent anion channel (VDAC), an outer membrane
mitochondrial protein, and adenine nucleotide transporter (ANT), an inner membrane
mitochondrial protein] and cytosol (Akt). In control experiments the primary antibody was
omitted. After washing in Solution A probes were incubated with secondary antibody
conjugated to Alexa Fluor 488, washed again, and analysed using the FL-1 flow cytometer
channel (Becton Dickinson FACSCalibur, Heidelberg, Germany) and CellQuest software.
Data were gated to exclude debris, and fluorescence of 20,000 particles was computed.
Representative FL-1 histograms from three independent mitochondria isolations are
presented.
Western blot analysis
Transmural biopsies of the left ventricle were snap-frozen in liquid nitrogen and tissue lysate
was prepared as described previously [12]. Accordingly, cell lysates from isolated
cardiomyocytes were prepared after trypsinization and sonication. Mitochondrial and
sarcolemmal samples were isolated as described above. In 50 μg samples of extracts
proteins were separated by standard SDS-PAGE methods and immunoreactive bands were
detected by enhanced chemiluminescence with LumiGLO (Cell Signaling Technology,
Beverly, MA). Representative western blots from at least three independent preparations are
presented. In addition, in preliminary experiments western blotting in HEK293 cells
overexpressing human A2BAR and in A2BAR knockout mice were done to document the
selectivity of the anti-A2B antibody and are more fully described in the online supplement.
Preparation of mitoplasts with digitonin digestion
Digitonin (Sigma, Saint Louis, MO) was prepared as described elsewhere [41] with slight
modifications. Briefly, digitonin was recrystalized with hot ethanol and dried at 100°C to
produce a fine powder. A 2% stock solution was than made by adding an appropriate
volume of solution B. Aliquots of mitochondrial suspensions (200 μg/100 μl solution B)
were placed on ice and 10 μl digitonin were added every minute up to 10 times, resulting in
final concentrations of 0, 0.75, 1.5, 2.25, 3.0 and 3.75 mg digitonin/mg mitochondrial
protein. The suspensions were incubated on ice for 30 min with oxygen access and gentle
stirring and were diluted with solution B. The diluted mitochondrial solutions were again
fractionated by centrifugation as described above and prepared for western blotting with
antibodies to A2BAR, ANT, and VDAC. Experiments were repeated twice and
representative western blots are presented.
Antibodies
The following antibodies and concentrations were used: rabbit polyclonal anti-human
A2BAR (1:50 for immunofluorescence microscopy and 1:500 for western blotting), goat
polyclonal anti-human calnexin (1:500), goat polyclonal anti-human ANT (1:500), goat
polyclonal VDAC-1 (1:500), rabbit polyclonal anti-rat Gαs (1:500), and donkey anti-goat
horseradish peroxidase linked IgG (1:5000). All were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-mouse Akt (1:1000), normal rabbit
IgG, horse anti-mouse horseradish peroxidase linked IgG, and goat anti-rabbit horseradish
peroxidase linked IgG (1:5000) were from Cell Signaling Technology (Beverly, MA), while
Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa Fluor 568-conjugated goat anti-
mouse IgG (1:200 each) were from Invitrogen (Karlsruhe, Germany). Monoclonal mouse
anti-rabbit Na+/K+-ATPase (1:250 for immunofluorescence and 1:2000 for western blotting)
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was from Millipore (Temicula, CA) and monoclonal mouse anti α-actinin (1:2000) from
Sigma (St. Louis, MO).
Statistics
Data are presented as mean ± SEM. Differences in infarct sizes, risk zones and TMRE
fluorescence amongst groups were compared by one-way ANOVA with Fisher LSD post
hoc testing. P<0.05 was considered to be significant.
Results
Infarct size measurements after A2BAR activation
As shown in Fig. 1A treating rat hearts at reperfusion with the highly selective A2BAR
agonist BAY60-6583 protected against ischemia/reperfusion injury. Protection was blocked
by co-administration of the selective A2BAR antagonist MRS1754, thus, A2B agonists are
also protective in the rat heart.
Assessment of mitochondrial membrane potential ΔΨm in isolated rat cardiomyocytes
Isolated cardiomyocytes were stressed with the calcium ionophore calcimycin which causes
mPTP formation related to calcium overload. Fig. 1B illustrates that treatment with
BAY60-6583 preserved ΔΨm compared to calcimycin-treated control cells and protection
was blocked by MRS1754. These results reveal an A2BAR-mediated response in individual
cardiomyocytes.
A2BAR mRNA expression in individual rat cardiomyocytes
Single cardiac myocytes were selected under a microscope and placed in the PCR tube to
insure that no other cell types were included. Quantitative RT-PCR analysis demonstrated
A2BAR mRNA expression in rat cardiomyocytes (Fig. 2). A2BAR mRNA was expressed as
a percentage of the housekeeping gene GAPDH, and easily detected in all of the tubes
tested. The agarose gel revealed that the amplified product was the predicted size based on
our primers. Finally, sequences from two of our samples were analysed. The sequencing
results showed 100 % homology with the A2B sequence in the GeneBank [gi|8392863|ref|
NM_017161.1 Rattus norvegicus adenosine A2B receptor (Adora2b) mRNA].
Immunofluorescence
Intracellular distribution of A2BAR in rat heart and isolated rat cardiomyocytes was
analyzed by immunofluorescence microscopy. A western blot of heart homogenate with the
antibody used for immunohistochemistry reveals a single strong band making nonspecific
staining unlikely (Fig. 3A). In response to the same antibody, HEK293 cells overexpressing
human A2BAR showed a similar single band which was not present in normal HEK293 cells
(supplemental Fig. S2). Furthermore, heart homogenate of A2BAR knockout mice no longer
showed the clear single band seen in wildtype animal hearts (supplemental Fig. S2),
suggesting that the antibody used indeed immunodetects A2BAR. Fig. 3B shows punctate
staining of the myocyte's cytosol and its nuclei but no staining of the sarcolemma. In
comparison, an immunofluorescent micrograph of HEK293 cells overexpressing A2BAR
recorded at the same magnification showed receptor localization at the plasma membrane
(Fig. 3C and supplemental Fig. S3). To make sure the absence of membrane staining was
not an artefact of the collagenase digestion used to disperse the myocytes, we examined a
cryosection of a rat ventricle. Figure 3D shows anti-A2BAR staining in green, and Fig. 3E
shows propidium iodide staining the nuclei red. Fig. 3F is the merged image. In addition to
the cytosolic and nuclear staining, string-like structures between the cells stained for A2BAR
and were presumed to be capillaries. Again there was no staining of cell membranes.
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Incubation of cardiomyocytes with purified IgG showed no staining (Fig. 3G). Cryosections
from wild-type mouse hearts showed a similar pattern which was fully absent in A2BAR
knock-out animals (supplemental Fig. S4), further indicating specificity of the signal.
Staining of cardiomyocytes with anti-A2BAR antibody (green), DAPI (blue) to label nuclei,
and anti-α-actinin antibody (red) to localize Z bands demonstrates integrity of isolated
myocytes and shows clear localization of staining within the nuclei, but there is no
association with the α-actinin-labelled Z bands (Fig. 4, upper panels). To test the hypothesis
that A2BAR might be located on mitochondria, co-staining with anti-A2B antibody and
MitoTracker Red was performed. As shown in the merged picture in Fig. 4, middle panel,
there was good co-localization of A2BAR and MitoTracker suggesting the receptors are
indeed on or very near the mitochondria. The lower panels of Fig. 4 showed only weak co-
staining of A2BARs and the sarcolemmal Na+/K+-ATPase, additionally demonstrating the
intracellular A2BAR localization. As expected, no immunoreactivity was detected in control
experiments with the corresponding IgG, and only the nuclei stained with DAPI were visible
(Fig. 4, lower panel, right).
Mitochondrial localization of A2BARs was further demonstrated by FACS analysis of
isolated mitochondria treated with antibodies recognizing A2BAR and marker proteins of
different compartments. As shown in Fig. 5A, A2BAR antibody binding to isolated
mitochondria was recognized by a shift of fluorescence intensity (population II) when
compared to controls (no primary antibody, population I). To further demonstrate that the
analyzed particles are most likely mitochondria, we treated them with antibodies against
mitochondrial marker proteins (VDAC, ANT). As seen in Fig. 5B, there is staining of
A2BAR, VDAC and ANT, and there is a rightward shift towards population II cells. The
same was true for Gαs (Fig. 5C), but not for the cytosolic marker Akt (Fig. 5D).
Western blot analysis
Fig. 6 shows that A2BAR immunoreactivity was detected in western blots of mitochondrial
preparations from left ventricular biopsies as well as isolated rat cardiomyocytes. In all
preparations the A2BAR band appeared at approximately 40 kDa, its expected size. In
addition to the A2BAR band in the mitochondrial fractions, the mitochondrial membrane
proteins ANT and VDAC were also evident and enriched compared to whole heart and cell
lysates. Gαs is known to couple to A2BAR and was detected in all fractions. In contrast,
neither mitochondrial fraction (whole heart or cardiomyocyte) demonstrated
immunoreactivity to the plasma membrane marker Na+/K+-ATPase, the sarcoplasmic
reticulum marker (calnexin), or the cytosolic marker (Akt). Mitochondria purification using
an additional percoll gradient showed no decrease in A2BAR content (supplemental Fig. S5)
Furthermore, two different sarcolemmal preparations were analysed, a 100,000 g pellet in
which mitochondrial contamination should be reduced by an upstream centrifugation step,
and a 100,000 g pellet further purified by a sucrose gradient. The high Na+/K+-ATPase
immunoreactivity of this preparation purified by sucrose gradient demonstrates sarcolemmal
enrichment (Fig. 6). While the normal 100,000 g pellet still contained mitochondrial (ANT,
VDAC) and SR (calnexin) contamination, this was much less the case when the sucrose
gradient step was added. Hence, the sucrose gradient was able to reduce mitochondrial
contamination, while SR was still present. A clear reduction of A2BAR in the sucrose
purified fraction supports our hypothesis of mitochondrial A2BAR localization. Not
surprisingly, strong signals for Gαs were present in both preparations related to the abundant
presence of GPCRs in the sarcolemma.
Mitochondria were incubated with increasing concentrations of digitonin to remove the
outer mitochondrial membrane (Fig. 7). Higher digitonin concentrations dissolve the outer
membrane of mitochondria as is confirmed by the loss of VDAC, a protein only present in
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the outer membrane. Conversely, the inner mitochondrial membrane marker ANT persists at
all concentrations of digitonin. Increasing concentrations of digitonin also caused loss of
A2BAR suggesting that they are also predominantly located in or near the outer
mitochondrial membrane.
Discussion
Considerable evidence indicates activation of A2BAR is cardioprotective. A2BAR selective
agonists limit infarct size in hearts subjected to ischemia/reperfusion [10,21,46]. In the
present study BAY60-6583 also protected the isolated rat heart when infused at the time of
reperfusion. Protection from postconditioning initiated with either ischemia or a PKC
activator could be blocked by co-administration of MRS1754 [21,33] which is a highly
selective inhibitor of A2BAR [19]. While these data imply that functional receptors must
reside in the heart, there is debate as to whether cardiomyocytes actually express them in
their plasma membranes. We were able to detect A2BAR mRNA transcripts using
quantitative RT-PCR in individually selected cardiomyocytes uncontaminated with other
cell types. Furthermore, western blot analysis of both heart biopsy and isolated
cardiomyocyte lysate showed a strong A2BAR band.
Since the A2BAR is a GPCR, we assumed that immunofluorescence would reveal plasma
membrane staining. To our surprise, the A2BAR antibody did not bind to the cardiomyocyte
sarcolemma as expected, but rather caused structures at intracellular sites to fluoresce. Co-
staining with propidium iodide or DAPI revealed high expression in nuclei. There was also a
chain-like pattern of fluorescent staining of intracellular structures with the A2B antibody
which resembled the pattern seen with mitochondrial stains in myocytes. The merged image
of A2BAR staining with staining generated by MitoTracker Red, a mitochondria-specific
dye, indicated co-localization of A2BAR and mitochondria. To further assess the likelihood
that A2BAR were in the sarcolemma, we exposed isolated cardiomyocytes simultaneously to
antibodies to A2BAR and Na+/K+-ATPase and found almost no co-localization of these two
proteins. In ventricular muscle cells surface receptors are often located on the T-tubules
which overlay the Z-lines deep in the cell. However, co-localization of A2BAR with Z-lines
stained with anti-actin antibody was also not observed.
In contrast to the findings in cardiomyocytes, HEK293 cells overexpressing A2BAR indeed
showed typical membrane staining by fluorochrome-linked A2BAR antibodies. While our
observations are consistent with recent reports of A2BAR localization [27,31], we have no
explanation for the differences between these cell models of A2BAR overexpression and the
pattern seen in primary adult cardiomyocytes.
Although it has been generally assumed that GPCRs are only trafficked to the plasma
membrane, there is evidence that GPCR can also localize and function in intracellular
compartments, such as the nucleus for the β-adrenergic receptor [7]. Also, mitochondrial
Ca2+ transport has been linked to the presence of P2Y-like receptors on mitochondria [2]
and Gαi subunits have been found in mitochondria of HEK293T cells [24]. Furthermore,
mitochondria are known to contain non-GPCR for estrogens, glucocorticoids, androgens,
and thyroid hormones, as well as the retinoid receptor α and the peroxisome proliferator-
activated receptor β [36].
Western blot analysis of mitochondrial preparations from hearts as well as isolated
cardiomyocytes showed A2BAR immunoreactivity (Fig. 6). The mitochondrial fractions
appeared to be nearly free of contamination with sarcolemma and sarcoplasmic reticulum as
revealed by a lack of reactivity to anti-Na+/K+-ATPase and anti-calnexin antibodies,
respectively. To further demonstrate an intracellular A2BAR localization we tried to isolate
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sarcolemma free of mitochondria and SR, which we hypothesized would not contain
A2BAR. First, a simple preparation including a centrifugation step at lower speed followed
by a high speed centrifugation step to pellet the sarcolemma was not sufficient because we
still saw contamination by mitochondria and SR proteins and, therefore, also A2BAR.
Further treatment with a sucrose gradient markedly reduced mitochondrial contamination.
Since the A2BAR signal also decreased without affecting SR content, A2BAR localization in
or near mitochondria is likely. Our digitonin studies additionally suggest A2BAR may reside
in the outer mitochondrial membrane. Nevertheless our studies do not unequivocally prove
that A2BAR reside within mitochondria; they may in fact only be loosely attached on the
outside. Moriyama and Sitkovsky [29] recently showed that A2BAR are poorly trafficked to
the membrane in some cells leaving many receptors in the endoplasmic reticulum of the
Golgi. However, the location of the receptors in our study is not consistent with a peri-
nuclear Golgi locus.
The molecular weight of our A2BAR band was near 40 kDa which closely approximates the
expected 38.18 kDa size. Previous studies have reported a tissue- and species-dependent
protein size between 31 and 50 kDa. For example, hexahistidine/FLAG-tagged human
A2BAR recombinantly expressed in HEK293 cells have molecular weights of 34.8 kDa and
after deglycosylation 31.3 kDa [23]. Puffinbarger et al. [37] demonstrated human A2BAR
with differing sizes, 35 kDa in small intestine, and 50-52 kDa in thymus, colon and placenta.
Jackson et al. [18] presented evidence for a 52 kDa A2BAR in rat aorta and preglomerular
microvasculature. It is difficult to explain the observed differences, but it is suspected that
the higher molecular weights were the result of antibodies cross-reacting with some non-
receptor epitope. In the present study the fact that the A2B band disappeared in tissue from
A2B knockout mice argues against non-specific binding of our antibody to another protein or
receptor subtype.
Functional relevance of cardiac A2BAR could be demonstrated by a BAY60-6583-mediated
decrease in infarct size after ischemia/reperfusion, and this protection was blocked with the
highly-selective A2BAR antagonist MRS1754. To test if cardiomyocytes, the cells that must
be protected at reperfusion, respond to A2BAR stimulation, we used a cell model of
intracellular calcium stress which mirrors the detrimental calcium increase occurring at
reperfusion [32]. Cardiomyocytes were stained with TMRE, and it is well accepted that a
loss in TMRE fluorescence is correlated with a loss of mitochondrial membrane potential
(ΔΨm), which in turn presumably indicates mPTP opening. When BAY60-6583 was added
before the calcium ionophore, cells were less prone to calcium-induced depolarization of
ΔΨm. This effect was inhibited by MRS1754. Confirmation of our results comes from a
recent study in which NECA, a potent A2AR agonist, suppressed mitochondrial transition
pore formation in isolated rat cardiomyocytes and, again, this protection could be blocked
with MRS1754 [44].
We do not know how A2BAR might be directed to mitochondria. Like 99% of the
mitochondrial proteins A2BAR are not part of the mitochondrial genome. Rather they are
encoded in the nuclear DNA. After being synthesized in the cytosol they must be transported
to the mitochondria. Most mitochondrial proteins carry importing sequences which are
recognized by cytosol-exposed receptors present in the mitochondrial outer membrane
called “translocase of the outer membrane” (TOM). Depending on the imported protein's
target they are transported by TOM and possibly by TIM (translocase of the inner
membrane) complexes [28]. Mitochondrial targeting moieties are quite variable and can be
present anywhere in the poly-peptide structure. However, as analyzed by either TargetP or
MITOPROT programs the A2BAR amino acid sequence does not contain any known
importation sequence [11]. This does not exclude the possibility that mitochondria will
incorporate them, however, as some imported mitochondrial proteins do not contain any of
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these sequences. This was recently found to be the case for connexin 43 which is present in
myocardial mitochondria [4,6,38].
Although still controversial, the survival kinases ERK, Akt and GSK-3β are central to the
protection conferred by pre- and postconditioning in the rat heart [13,15,42] and they can
localize in mitochondria as well. As reviewed by Poderoso et al. [35] activation of protein
kinase A (PKA), MEK1/2 and ERK1/2 leads to signal complex formation at the
mitochondrion surface. GSK-3β which is cardioprotective when inhibited by
phosphorylation is present in mitochondria [17], and Akt reportedly accumulates in
mitochondria following PI3-kinase activation [3]. In our study we used Akt as a cytosolic
marker and did not see immunoreactivity in our mitochondrial preparations. But our cells
were in a basal, unstimulated state.
A2BAR couple through stimulatory G proteins (Gαs) which in turn are known to produce
cAMP via adenylyl cyclase. Indeed several G proteins were identified in mitochondria of
HEK293T cells [24]. And we found Gαs in our mitochondrial preparation. Sardanelli et al.
[40] showed PKA in mitochondria from rat hearts, while Acin-Perez et al. [1] demonstrated
cAMP production within mitochondria and the subsequent activation of mitochondrial PKA.
Furthermore, nitric oxide synthase and its product nitric oxide could also be demonstrated
within mitochondria [20]. Although the presence of A2BAR in or near mitochondria is
likely, the demonstration of a functional relevance of these receptor complexes surely
requires further study.
There is growing evidence that protection afforded by pre- and postconditioning is related to
kinase- and signalling molecule-dependent inhibition of mitochondrial transition pores upon
reperfusion [5,9,16] and that A2BAR control them [33]. It therefore seems quite conceivable
that A2BAR localized on mitochondria could be involved in this signalling cascade.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Thomas Krahn and Barbara Albrecht (Bayer HealthCare Wuppertal, Germany) for providing
BAY60-6583 and performing the concentration measurements (see supplemental material). We thank Dr J Linden,
University of Virginia, Charlottesville, VA, for the HEK293-A2BAR cells, and Dr H Eltzschig, University of
Colorado, Denver, CO for the A2BAR knock-out mice (see supplemental material).
Funding
The study was in part supported by grants from the National Institutes of Health Heart, Lung and Blood Institute
HL-20648 (T.K., J.M.D.) and the Deutsche Forschungsgemeinschaft (T.K.).
References
1. Acin-Perez R, Salazar E, Kamenetsky M, Buck J, Levin LR, Manfredi G. Cyclic AMP produced
inside mitochondria regulates oxidative phosphorylation. Cell Metab. 2009; 9:265–276. DOI:
10.1016/j.cmet.2009.01.012. [PubMed: 19254571]
2. Belous AE, Jones CM, Wakata A, Knox CD, Nicoud IB, Pierce J, Chari RS. Mitochondrial calcium
transport is regulated by P2Y1- and P2Y2-like mitochondrial receptors. J.Cell Biochem. 2006;
99:1165–1174. DOI: 10.1002/jcb.20985. [PubMed: 16795051]
3. Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-
kinase activation. J Neurochem. 2003; 87:1427–1435. DOI: 10.1046/j.1471-4159.2003.02113.x.
[PubMed: 14713298]
Grube et al. Page 10










4. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I,
Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, Schulz R. Connexin 43 in cardiomyocyte
mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005; 67:234–244.
DOI: 10.1016/j.cardiores.2005.04.014. [PubMed: 15919068]
5. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore
opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res
Cardiol. 2010; 105:771–85. DOI: 10.1007/s00395-010-0124-1. [PubMed: 20960209]
6. Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G,
Schulz R. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte
mitochondria. Basic Res Cardiol. 2009; 104:141–7. DOI: 10.1007/s00395-009-0007-5. [PubMed:
19242638]
7. Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve LR, Ethier N, Trieu P, Allen BG, Hébert TE.
Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse
ventricular cardiomyocytes. Cardiovasc Res. 2006; 71:69–78. DOI: 10.1016/j.cardiores.
2006.03.015. [PubMed: 16631628]
8. Cohen MV, Yang X-M, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and
phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening
mitochondrial KATP channels. Circ Res. 2001; 89:273–8. DOI: 10.1161/hh1501.094266. [PubMed:
11485978]
9. Di Lisa F, Canton M, Menabò R, Dodoni G, Bernardi P. Mitochondria and reperfusion injury. The
role of permeability transition. Basic Res Cardiol. 2003; 98:235–241. DOI: 10.1007/
s00395-003-0415-x. [PubMed: 12835952]
10. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H,
Thompson LF, Unertl K, Eltzschig HK. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B
adenosine receptors. Circulation. 2007; 115:1581–1590. DOI: 10.1161/circulationaha.106.669697.
[PubMed: 17353435]
11. Emanuelsson O, Nielsen H, Brunak S, von Heijne G. Predicting subcellular localization of proteins
based on their N-terminal amino acid sequence. J Mol Biol. 2000; 300:1005–1016. DOI: 10.1006/
jmbi.2000.3903. [PubMed: 10891285]
12. Förster K, Paul I, Solenkova N, Staudt A, Cohen MV, Downey JM, Felix SB, Krieg T. NECA at
reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition
pore by activating p70S6 kinase. Basic Res Cardiol. 2006; 101:319–326. DOI: 10.1007/
s00395-006-0593-4. [PubMed: 16604438]
13. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion
injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;
61:448–460. DOI: 10.1016/j.cardiores.2003.09.024. [PubMed: 14962476]
14. Haynes J Jr, Obiako B, Thompson WJ, Downey JM. Adenosine-induced vasodilation: receptor
characterization in pulmonary circulation. Am J Physiol Heart Circ Physiol. 1995; 268:H1862–
H1868.
15. Heusch G, Boengler K, Schulz R. Cardioprotection. Nitric oxide, protein kinases, and
mitochondria. Circulation. 2008; 118:1915–9. DOI: 10.1161/circulationaha.108.805242. [PubMed:
18981312]
16. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening:
the holy grail of cardioprotection. Basic Res Cardiol. 2010; 105:151–4. DOI: 10.1007/
s00395-009-0080-9. [PubMed: 20066536]
17. Hoshi M, Sato M, Kondo S, Takashima A, Noguchi K, Takahashi M, Ishiguro K, Imahori K.
Different localization of tau protein kinase I/glycogen synthase kinase-3β from glycogen synthase
kinase-3α in cerebellum mitochondria. J Biochem. 1995; 118:683–685. [PubMed: 8576078]
18. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular
microcirculation. Am J Physiol Renal Physiol. 2002; 283:F41–F51. DOI: 10.1152/ajprenal.
00232.2001. [PubMed: 12060585]
19. Ji X, Kim YC, Ahern DG, Linden J, Jacobson KA. [3H]MRS 1754, a selective antagonist
radioligand for A2B adenosine receptors. Biochem Pharmacol. 2001; 61:657–663. DOI: 10.1016/
s0006-2952(01)00531-7. [PubMed: 11266650]
Grube et al. Page 11










20. Kanai AJ, Pearce LL, Clemens PR, Birder LA, Van Bibber MM, Choi S-Y, de Groat WC, Peterson
J. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using
electrochemical detection. Proc Natl Acad Sci U S A. 2001; 98:14126–14131. DOI: 10.1073/pnas.
241380298. [PubMed: 11717466]
21. Kuno A, Critz SD, Cui L, Solodushko V, Yang X-M, Krahn T, Albrecht B, Philipp S, Cohen MV,
Downey JM. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of
adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol. 2007; 43:262–
271. DOI: 10.1016/j.yjmcc.2007.05.016. [PubMed: 17632123]
22. Liang BT, Haltiwanger B. Adenosine A2a and A2b receptors in cultured fetal chick heart cells.
High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.
Circ Res. 1995; 76:242–251. [PubMed: 7834835]
23. Linden J, Thai T, Figler H, Jin X, Robeva AS. Characterization of human A2B adenosine
receptors: radioligand binding, western blotting, and coupling to Gq in human embryonic kidney
293 cells and HMC-1 mast cells. Mol Pharmacol. 1999; 56:705–713. [PubMed: 10496952]
24. Lyssand JS, Bajjalieh SM. The heterotrimeric G protein subunit Gαi is present on mitochondria.
FEBS Lett. 2007; 581:5765–5768. DOI: 10.1016/j.febslet.2007.11.044. [PubMed: 18037379]
25. Maas JE, Wan TC, Figler RA, Gross GJ, Auchampach JA. Evidence that the acute phase of
ischemic preconditioning does not require signaling by the A2B adenosine receptor. J Mol Cell
Cardiol. 2010; 49:886–893. DOI: 10.1016/j.yjmcc.2010.08.015. [PubMed: 20797398]
26. Maas O, Donat U, Frenzel M, Rütz T, Kroemer HK, Felix SB, Krieg T. Vardenafil protects
isolated rat hearts at reperfusion dependent on GC and PKG. Br J Pharmacol. 2008; 154:25–31.
DOI: 10.1038/bjp.2008.71. [PubMed: 18332860]
27. Matharu AL, Mundell SJ, Benovic JL, Kelly E. Rapid agonist-induced desensitization and
internalization of the A2B adenosine receptor is mediated by a serine residue close to the COOH
terminus. J Biol Chem. 2001; 276:30199–30207. DOI: 10.1074/jbc.M010650200. [PubMed:
11333255]
28. Mokranjac D, Neupert W. Thirty years of protein translocation into mitochondria: unexpectedly
complex and still puzzling. Biochim Biophys Acta. 2009; 1793:33–41. DOI 10.1016/j.bbamcr.
2008.06.021. [PubMed: 18672008]
29. Moriyama K, Sitkovsky MV. Adenosie A2A receptor is involved in cell surface expression of A2B
receptor. J Biol Chem. 2010; 285:39271–88. DOI: 10.1074/jbc.M109.098293. [PubMed:
20926384]
30. Morrison RR, Talukder MA, Ledent C, Mustafa SJ. Cardiac effects of adenosine in A2A receptor
knockout hearts: uncovering A2B receptors. Am J Physiol Heart Circ Physiol. 2002; 282:H437–
H444. DOI: 10.1152/ajpheart.00723.2001. [PubMed: 11788390]
31. Mundell SJ, Matharu AL, Kelly E, Benovic JL. Arrestin isoforms dictate differential kinetics of
A2B adenosine receptor trafficking. Biochemistry. 2000; 39:12828–12836. DOI: 10.1021/
bi0010928. [PubMed: 11041847]
32. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, Scorrano L, Pagano F, Prato M, Di Lisa F,
Bernardi P. Arachidonic acid released by phospholipase A2 activation triggers Ca
2+-dependent
apoptosis through the mitochondrial pathway. J Biol Chem. 2004; 279:25219–25225. DOI:
10.1074/jbc.M310381200. [PubMed: 15070903]
33. Philipp S, Yang X-M, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit
hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006; 70:308–
314. DOI: 10.1016/j.cardiores.2006.02.014. [PubMed: 16545350]
34. Piper HM, Probst I, Schwartz P, Hutter FJ, Spieckermann PG. Culturing of calcium stable adult
cardiac myocytes. J Mol Cell Cardiol. 1982; 14:397–412. DOI: 10.1016/0022-2828(82)90171-7.
[PubMed: 7175947]
35. Poderoso C, Maloberti P, Duarte A, Neuman I, Paz C, Maciel FC, Podesta EJ. Hormonal activation
of a kinase cascade localized at the mitochondria is required for StAR protein activity. Mol Cell
Endocrinol. 2009; 300:37–42. DOI: 10.1016/j.mce.2008.10.009. [PubMed: 19007846]
36. Psarra AM, Sekeris CE. Nuclear receptors and other nuclear transcription factors in mitochondria:
regulatory molecules in a new environment. Biochim Biophys Acta. 2008; 1783:1–11. DOI:
10.1016/j.bbamcr.2007.10.021. [PubMed: 18062929]
Grube et al. Page 12










37. Puffinbarger NK, Hansen KR, Resta R, Laurent AB, Knudsen TB, Madara JL, Thompson LF.
Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b
receptor. Mol Pharmacol. 1995; 47:1126–1132. [PubMed: 7603451]
38. Rottlaender D, Boengler K, Wolny M, Michels G, Endres-Becker J, Motloch LJ, Schwaiger A,
Buechert A, Schulz R, Heusch G, Hoppe UC. Connexin 43 acts as a cytoprotective mediator of
signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin
Invest. 2010; 120:1441–53. DOI:10.1172/jci40927. [PubMed: 20364086]
39. Rubino A, Ralevic V, Burnstock G. Contribution of P1-(A2b subtype) and P2-purinoceptors to the
control of vascular tone in the rat isolated mesenteric arterial bed. Br J Pharmacol. 1995; 115:648–
652. [PubMed: 7582485]
40. Sardanelli AM, Signorile A, Nuzzi R, Rasmo DD, Technikova-Dobrova Z, Drahota Z, Occhiello
A, Pica A, Papa S. Occurrence of A-kinase anchor protein and associated cAMP-dependent
protein kinase in the inner compartment of mammalian mitochondria. FEBS Lett. 2006; 580:5690–
5696. DOI: 10.1016/j.febstel.2006.09.020. [PubMed: 16996504]
41. Schnaitman C, Erwin VG, Greenawalt JW. The submitochondrial localization of monoamine
oxidase. An enzymatic marker for the outer membrane of rat liver mitochondria. J Cell Biol. 1967;
32:719–735. [PubMed: 4291912]
42. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G.
Ischemic postconditioning in pigs. No causal role for RISK activation. Circ Res. 2009; 104:15–8.
DOI: 10.1161/circresaha.108.186429. [PubMed: 19038864]
43. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects
preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart
Circ Physiol. 2006; 290:H441–H449. DOI: 10.1152/ajpheart.00589.2005. [PubMed: 16155103]
44. Xi J, McIntosh R, Shen X, Lee S, Chanoit G, Criswell H, Zvara DA, Xu Z. Adenosine A2A and
A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.
J Mol Cell Cardiol. 2009; 47:684–690. DOI: 10.1016/j.yjmcc.2009.08.009. [PubMed: 19695259]
45. Xin W, Cohen MV, Rich TC, Downey JM. Which preconditioning-associated G protein-coupled
receptors are expressed on the sarcolemma? FASEB J. 2009; 23:793.
46. Xu Z, Mueller RA, Park S-S, Boysen PG, Cohen MV, Downey JM. Cardioprotection with
adenosine A2 receptor activation at reperfusion. J Cardiovasc Pharmacol. 2005; 46:794–802.
[PubMed: 16306804]
47. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C,
Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B
adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest.
2006; 116:1913–1923. DOI: 10.1172/jci27933. [PubMed: 16823489]
Grube et al. Page 13











A. Infarct size in isolated rat hearts expressed as a percentage of the risk zone. Open circles
denote individual experiments, while filled-in circles are group means±SEM. *p<0.001 B.
Assessment of mitochondrial membrane potential ΔΨm in isolated cardiomyocytes.
Whereas control cells were treated with only calcimycin, other cells were also exposed to
BAY 60-6583 alone or a combination of BAY 60-6583 and MRS1754. *p<0.05
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A2BAR-mRNA expression in isolated rat cardiomyocytes. Quantitative RT-PCR showed
A2BAR mRNA copy count was low but measurable as compared with GAPDH. The gel
demonstrates that the amplified transcripts were of the size these primers were expected to
produce.
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A. Western blot of heart homogenate with anti-A2B antibody revealing a single strong band.
In Fig. 3B-3G cardiomyocytes, HEK293 cells overexpressing A2BAR, and cryosections of
rat heart slices were stained with A2BAR antibody coupled to a fluorochrome (green). B.
Isolated rat cardiomyocytes with punctate intracellular and nuclear staining, but no staining
of sarcolemma. C. Plasma membrane staining in HEK293 cells overexpressing A2BAR at
identical magnification as in Fig. 3B. D. Slices of rat left ventricle showing diffuse
intracellular and nuclear A2BAR staining. E. Propidium iodide staining of the nuclei. F.
Merged image of Figs. 3D and 3E. G. Control with cardiomyocytes incubated with IgG.
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Isolated rat cardiomyocytes were stained with A2BAR antibody coupled to a fluorochrome
(green). Additionally, nuclei, Z bands, mitochondria and Na+/K+-ATPase were detected
using DAPI, α-actinin antibody, MitoTracker Red and Na+/K+-ATPase antibody,
respectively. A2BAR green fluorescence was observed in nuclei but not in plasma
membranes or Z bands (upper panel). Intracellular staining for A2BAR localized to
mitochondria (middle panel). Intracellular A2BAR staining did not co-localize with
sarcolemmal Na+/K+-ATPase (lower panel). DAPI-stained nuclei are visible in control
cardiomyocytes incubated with IgG instead of specific primary antibody (lower panel, right
image).
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Isolated mitochondria were stained with different primary antibodies and corresponding
secondary antibody coupled to green fluorescent 488 dye and subjected to FACS analysis.
A. Anti-A2B antibody-stained mitochondria showed a marked rightward shift. Mitochondria
stained with mitochondrial marker proteins VDAC and ANT (B) and Gαs (C) similarly
showed rightward shifts, suggesting mitochondrial A2BAR and G protein co-localization. D.
The purity of the mitochondrial preparation was demonstrated by using Akt as a cytosolic
marker which had no effect.
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Western blot of different rat heart preparations revealed mitochondrial localization of
A2BAR protein. Purity of mitochondrial samples from hearts and isolated cardiomyocytes
was demonstrated by co-staining of different marker proteins. The heart mitochondria
samples were free of plasma membrane (Na+/K+-ATPase), sarcoplasmic reticulum
(calnexin), and cytosol (Akt). Absence of A2BAR in sarcolemma was demonstrated by two
different membrane preparations in which Na+/K+-ATPase was enriched. 100,000 g pellets
still contained SR and mitochondria and, therefore, stained positive for A2BAR, while
further purification with a sucrose gradient greatly reduced mitochondrial contamination
together with A2BAR staining.
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Western blot analysis of mitochondrial preparations treated with increasing digitonin
concentrations. The signal for the outer membrane marker voltage-dependent anion channel
(VDAC) is lost at higher concentrations, while the inner membrane marker protein adenine
nucleotide transporter (ANT) is still present even at the highest digitonin concentration.
Since A2BAR and VDAC bands were similarly affected by digitonin, a location for the
former in the outer mitochondrial membrane is assumed.
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